Status: Recruiting
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
The purpose of this study is to evaluate the long-term safety and tolerability of Xanomeline and Trospium Chloride for the treatment of psychiatric disorders in children and adolescents
Participants needed: 400
Trial details
Phase: Phase 3Age: 5-17Biological sex: AllType: InterventionalSponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb companyUpdated: Sep 22, 2026Locations: 94
Eligibility criteria
Participants must have completed the double-blind treatment period (ie, Visit 8)... [+1]
Participants must not have a significant risk of committing violent acts, seriou... [+3]